Recon: Pfizer, Moderna seek EUA for bivalent boosters for kids; Daiichi Sankyo wins Japanese approval for blood cancer drug Ezharmia
ReconMichael Mezher
Biologics/ biosimilars/ vaccinesBiotechnologyDiagnostics/IVDsEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy